Related Experiment Video
Updated: Aug 9, 2026
08:20
Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
Adverse drug interactions in dental practice. Professional and educational implications
P A Moore1, T W Gage, E V Hersh
1University of Pittsburgh, School of Dental Medicine, Department of Dental Public Health, Pa. 15261, USA.
Journal of the American Dental Association (1939)
|January 27, 1999
Summary
Dental professionals must stay updated on drug interactions. This review identifies clinically significant drug interactions relevant to dental practice, offering guidance to prevent adverse events.
Area of Science:
- Dental Pharmacology
- Clinical Therapeutics
- Drug Interaction Analysis
Background:
- Dental pharmacotherapeutics are rapidly evolving, necessitating continuous clinician education on new drugs and interactions.
- This article initiates a series addressing adverse drug interactions relevant to common dental practice agents.
Purpose of the Study:
- To identify and evaluate clinically significant drug interactions pertinent to dental practice.
- To provide evidence-based recommendations for managing these interactions and preventing adverse events.
Main Methods:
- An expert panel of dentist/clinical pharmacologists reviewed and assessed the literature on dental drug interactions.
- The quality and severity of reported interactions were evaluated to determine clinical relevance.
Main Results:
- Many reported drug interactions are poorly documented or of minor importance in dental settings.
- A system for rating the significance of dental drug interactions was developed and applied.
Conclusions:
- Only a limited number of reported drug interactions have significant clinical relevance for dental practitioners.
- Understanding and avoiding these key interactions is crucial for preventing severe adverse reactions in dental practice.
Related Concept Videos
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...